📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis. (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.4409

PubMed Identifier: 26160844

Publication URI: http://europepmc.org/abstract/MED/26160844

Type: Journal Article/Review

Volume: 6

Parent Publication: Oncotarget

Issue: 27

ISSN: 1949-2553